Showing 601 - 620 results of 123,131 for search '(( 10 mean decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.63s Refine Results
  1. 601

    Decrease in IL-4 measured by standard ELISA. by Albert S. Jun (231619)

    Published 2011
    “…<p>Samples shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0016437#pone.0016437.s002" target="_blank">Table S2</a> were pooled into 13 control and 10 keratoconus samples (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0016437#s4" target="_blank">Methods</a>). …”
  2. 602
  3. 603
  4. 604
  5. 605
  6. 606

    Decrease of 4 Asp isomers at 70°C. by Kenzo Aki (386666)

    Published 2013
    “…<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0058515#pone-0058515-g007" target="_blank">Figure 7a:</a> decrease of L-α-Asp with incubation of T6-Lα peptide at 70°C. …”
  7. 607
  8. 608
  9. 609
  10. 610
  11. 611
  12. 612
  13. 613
  14. 614
  15. 615

    Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

    Published 2013
    “…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”
  16. 616

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”
  17. 617

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  18. 618
  19. 619
  20. 620